
Natco Pharma and its marketing partner in the USA, Breckenridge
Pharmaceutical, Inc., has filed an Abbreviated New Drug Application
(ANDA) for Bendamustine Hydrochloride powder; IV infusion (25mg/vial and
100mg/vial).
For more information ✆ - 0731-6642300 or Visit https://www.epicresearch.co/
No comments:
Post a Comment